Maintenance Aromatase Inhibitors (AIs)+ Everolimus vs AIs in Hormone Receptor Positive Metastatic Breast Cancer Patients
Status:
Completed
Trial end date:
2020-07-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare maintenance Aromatase Inhibitors (AIs) + everolimus
with Aromatase Inhibitors alone after 1st line chemotherapy in patients with HR+ metastatic
breast cancer.